Curator Highlights

Last updated: 2026-04-19 | 0 active highlights — all marks resolved 2026-04-19

How this works:

  • Add highlights in Obsidian using ==text== on any wiki page (standard highlight, no colour)
  • For colour-coded verification highlights, use Obsidian’s <mark style="background: #COLOUR;">text</mark> syntax
  • Add a comment by placing “ immediately after the highlight on the same line: ==text==
  • To resolve: remove the ==...== or <mark> markers from the source page
  • This page is auto-regenerated during lint and on “update highlights” — do not edit manually

Colour Code Legend

ColourHexMeaning
🟢 Green#BBFABBA6Verified against raw source file — claim confirmed correct
🔴 Red#FF5582A6Could not verify in raw source file — claim absent, modified, or misstated
🟠 Orange#FFB86CA6Important curator note — verify claim against sources, or methodological caveat
🔵 Blue#ADCCFFA6Better to add a wikilink to a source or related page here
🩷 Pink#FFB8EBA6Curator-highlighted important idea worth returning to

Resolution Log

ANA and Dengue - Review V2.0 — resolved 2026-04-19

All marks resolved. Summary of actions taken:

🟢 Green (20 marks) — all claims verified against raw source PDFs. Marks stripped; text unchanged.

🟠 Orange (6 marks) — resolved as follows:

MarkResolution
serum dilution of 1:100 (Berlin2007, §1.4)Concern already addressed in text (fold-change framed as the interpretable metric). Mark stripped.
(Viral n=23, 21.7% ANA positivity) (§2.2)Small-n caveat already noted in surrounding text. Mark stripped.
The main negative point is the serum dilution ratio was not noted… (§3.1)Informal curator note rewritten as formal analytical prose: “Key limitation for cross-study comparison. Chatterjee2024 does not report the IIFA serum dilution…” Mark stripped.
suggesting (§3.2)Word already appropriately hedges the inference. Curator Highlights note preserved in this log. Mark stripped.
This non-specific fraction is now mechanistically named (§3.2)Framing validated after Zhou2007 terminological note was added to §3.2 (previous session). Mark stripped.
for IgM (§3.2, half-life bullet)Bullet expanded to explicitly contrast: “Serum half-life ~8 hours for IgM (contrast: IgG half-life ~21 days…).” Mark stripped.

🔵 Blue (1 mark)germline-encoded polyreactive IgM (§1.3): wikilink added → [[Polyreactive Antibodies|germline-encoded polyreactive IgM]]. Mark stripped.

🩷 Pink (4 marks) — important ideas confirmed as well-stated in text. No text changes required. Marks stripped. Ideas preserved in the text:

  • Female/older cohort demographic confounding (§2.1)
  • Dengue must exceed generic viral ANA elevation benchmark (§2.2)
  • “Persistence requires an explanation.” (§2.2)
  • Non-specific IIFA excess is dengue-specific, not generic febrile illness (§3.2)

Antinuclear Antibodies — resolved 2026-04-19

🟢 Green (15 marks) — all claims verified against raw source PDFs. Marks stripped; text unchanged.

🔴 Red (2 marks) — both investigated and corrected in a prior session (2026-04-18 to 2026-04-19):

  1. ~86% of individuals who test ANA-positive at 1:80 do not have SLE — figure not found in any cited source. Replaced with accurate prevalence-derived statement (Satoh2012/Dinse2022).
  2. HAV patients were positive for all 8 tested ANA specificities — Berlin2007 Results states only three of ten HAV patients; Discussion overstated this. Wiki corrected to follow Results. Berlin2007 source page updated with ⚠ internal discrepancy note.

No active highlights remain. Add new marks in Obsidian to begin a new annotation cycle.